Evidence map›Paper›PMID 34781986›Full record

ArticleCritical care (London, England)2021

Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.

Jose Angel Lorente, Nicolas Nin, Palmira Villa, Dovami Vasco, Ana B Miguel-Coello, Ignacio Rodriguez, Raquel Herrero, Oscar Peñuelas, Jesús Ruiz-Cabello, Jose L Izquierdo-Garcia

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. αInternational journal of molecular sciences · 2023
    Review
  18. Review
  19. Article
  20. NMR-Metabolomics in COVID-19 Research.Advances in experimental medicine and biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jose Angel LorenteCIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Nicolas NinHospital Español, Montevideo, Uruguay.
Palmira VillaCentro de Asistencia a La Investigación Bioimagen Complutense, Universidad Complutense de Madrid, Madrid, Spain.
Dovami VascoDepartment of Critical Care, Hospital Universitario de Getafe, Madrid, Spain.
Ana B Miguel-CoelloCIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Ignacio RodriguezCIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Raquel HerreroDepartment of Critical Care, Hospital Universitario de Getafe, Madrid, Spain.
Oscar PeñuelasDepartment of Critical Care, Hospital Universitario de Getafe, Madrid, Spain.
Jesús Ruiz-CabelloCIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Jose L Izquierdo-GarciaCIBER de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, Madrid, Spain. jlizquierdo@ucm.es.ORCID 0000-0002-7907-3776
Universidad Complutense de Madrid · ESHospital Universitario de Getafe · ESInstituto de Salud Carlos III · ES

Funding

MARIHUANA EFFECTS ON TESTIS AND BEHAVIOR IN MICER01DA003875 · NIDA · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI BARTKE, ANDRZEJ · 1985 to 1988
–
Agencia Nacional de Investigación e Innovación Fondo Sectorial de Salud (155219)Comunidad de Madrid B2017/BMD3875Comunidad de Madrid S2017/BMD-3727-EXOHEP-CMFundación BBVA Ayudas a Equipos de Investigación Científica de Biomedicina 2018Horizon 2020 823854 (INNOVA4TB)"la Caixa" Foundation HR20-00075Ministerio de Ciencia e Innovación MDM-2017-0720Ministerio de Ciencia e Innovación PID2019-10656RJ-I00Ministerio de Economía y Competitividad SAF2017-84494-C2-1-ROsasun Saila, Eusko Jaurlaritzako KK-2019/bmG19
6 · The paper itself

Abstract

backgroundAcute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by lung inflammation and pulmonary edema. Coronavirus disease 2019 (COVID-19) is associated with ARDS in the more severe cases. This study aimed to compare the specificity of the metabolic alterations induced by COVID-19 or Influenza A pneumonia (IAP) in ARDS.

methodsEighteen patients with ARDS due to COVID-19 and twenty patients with ARDS due to IAP, admitted to the intensive care unit. ARDS was defined as in the American-European Consensus Conference. As compared with patients with COVID-19, patients with IAP were younger and received more often noradrenaline to maintain a mean arterial pressure > 65 mm Hg. Serum samples were analyzed by Nuclear Magnetic Resonance Spectroscopy. Multivariate Statistical Analyses were used to identify metabolic differences between groups. Metabolic pathway analysis was performed to identify the most relevant pathways involved in ARDS development.

resultsARDS due to COVID-19 or to IAP induces a different regulation of amino acids metabolism, lipid metabolism, glycolysis, and anaplerotic metabolism. COVID-19 causes a significant energy supply deficit that induces supplementary energy-generating pathways. In contrast, IAP patients suffer more marked inflammatory and oxidative stress responses. The classificatory model discriminated against the cause of pneumonia with a success rate of 100%.

conclusionsOur findings support the concept that ARDS is associated with a characteristic metabolomic profile that may discriminate patients with ARDS of different etiologies, being a potential biomarker for the diagnosis, prognosis, and management of this condition.

Indexed as

Influenza A Virus, H1N1 SubtypeAdultAgedCOVID-19FemaleHumansInfluenza, HumanMaleMiddle AgedRespiratory Distress SyndromeARDSCOVID-19DiagnosisH1N1 influenzaMetabolomicsNMR

Identifiers

PMID34781986
PMCPMC8591432
OpenAlexW3212098421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.